As of close of business last night, Sotera Health Company’s stock clocked out at $14.30, down -1.85% from its previous closing price of $14.57. In other words, the price has decreased by -$0.27 from its previous closing price. On the day, 989788 shares were traded. SHC stock price reached its highest trading level at $14.59 during the session, while it also had its lowest trading level at $14.26.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
To gain a deeper understanding of SHC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 6.36 whereas as Long-Term Debt/Eq ratio is at 6.33.
Upgrades & Downgrades
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4.60B and an Enterprise Value of 6.23B. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.21 while its Price-to-Book (P/B) ratio in mrq is 11.09. Its current Enterprise Value per Revenue stands at 6.31 whereas that against EBITDA is -51.50.
Stock Price History:
Over the past 52 weeks, SHC has reached a high of $24.90, while it has fallen to a 52-week low of $5.78. The 50-Day Moving Average of the stock is 16.43, while the 200-Day Moving Average is calculated to be 13.35.
It appears that SHC traded 1.04M shares on average per day over the past three months and 1.18M shares per day over the past ten days. A total of 280.69M shares are outstanding, with a floating share count of 273.64M. Insiders hold about 0.40% of the company’s shares, while institutions hold 88.20% stake in the company. Shares short for SHC as of Apr 27, 2023 were 4.53M with a Short Ratio of 4.53M, compared to 4.62M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.60% and a Short% of Float of 4.55%.
As of right now, 7 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.17 for the current quarter, with a high estimate of $0.19 and a low estimate of $0.16, while EPS last year was $0.27. The consensus estimate for the next quarter is $0.23, with high estimates of $0.24 and low estimates of $0.22.
Analysts are recommending an EPS of between $0.83 and $0.75 for the fiscal current year, implying an average EPS of $0.8. EPS for the following year is $0.92, with 7 analysts recommending between $0.97 and $0.84.
In the current quarter, 5 analysts expect revenue to total $258.93M. It ranges from a high estimate of $263M to a low estimate of $255M. As of the current estimate, Sotera Health Company’s year-ago sales were $266.64M, an estimated decrease of -2.90% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $289.41M, an increase of 16.60% over than the figure of -$2.90% in the same quarter last year. There is a high estimate of $292.6M for the next quarter, whereas the lowest estimate is $285.64M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.07B, while the lowest revenue estimate was $1.06B, resulting in an average revenue estimate of $1.07B. In the same quarter a year ago, actual revenue was $1B, up 6.60% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $1.17B in the next fiscal year. The high estimate is $1.19B and the low estimate is $1.14B. The average revenue growth estimate for next year is up 9.00% from the average revenue estimate for this year.